Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case series
- PMID: 37067070
- PMCID: PMC10116941
- DOI: 10.1080/21645515.2023.2199653
Temporal association between COVID-19 vaccination and Raynaud's phenomenon: A case series
Abstract
COVID-19 vaccine-related adverse events are mostly minor to moderate, and serious events are rare. Single cases of Raynaud's phenomenon (RP) in temporal proximity to COVID-19 vaccination have been reported. Demographic data, medical history, and detailed information regarding vaccination status and RP characteristics were obtained from patients with confirmed RP after COVID-19 vaccination. Fifteen participants reported the initial manifestation of RP, which occurred in 40% after the first, in 33% after the second, and in 27% after the third vaccination. RP development and occurrence of episodes were not linked to any specific vaccine type. New onset of disease was observed in 40% of the vaccinees after BNT162b2, in 33% after mRNA-1273, and in 27% after ChAdOx1 vaccination. Three out of four participants with preexisting RP prior to COVID-19 vaccination reported aggravation in frequency and intensity after immunization. Although COVID-19 vaccination is pivotal in controlling the pandemic, the observed temporal association between vaccine administration and RP occurrence warrants global activities to support pharmacovigilance for the detection of adverse reactions, one of which may include RP.
Keywords: BNT162b2 vaccine; COVID-19 vaccination; COVID-19 vaccine; ChAdOx1 vaccine; Raynaud’s phenomenon; Raynaud’s syndrome; adverse effect; mRNA-1273 vaccine.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures

Comment in
-
Special focus on the association between COVID-19 vaccination and Raynaud's phenomenon in autoimmune disease.Hum Vaccin Immunother. 2023 Dec 15;19(3):2295077. doi: 10.1080/21645515.2023.2295077. Epub 2023 Dec 18. Hum Vaccin Immunother. 2023. PMID: 38109761 Free PMC article. No abstract available.
References
-
- World Health Organization . WHO coronavirus (COVID-19) dashboard. [accessed 2023 Mar 15]. https://covid19.who.int/.
-
- Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N.. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect. 2022;28(2):202–21. doi:10.1016/j.cmi.2021.10.005. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical